vs

Side-by-side financial comparison of Alpha Metallurgical Resources, Inc. (AMR) and INSMED Inc (INSM). Click either name above to swap in a different company.

Alpha Metallurgical Resources, Inc. is the larger business by last-quarter revenue ($519.1M vs $263.8M, roughly 2.0× INSMED Inc). Alpha Metallurgical Resources, Inc. runs the higher net margin — -3.3% vs -124.5%, a 121.2% gap on every dollar of revenue. On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs -15.7%). Alpha Metallurgical Resources, Inc. produced more free cash flow last quarter ($-10.0M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs -22.4%).

Alpha Metallurgical Resources, formerly Contura Energy, is a leading coal supplier with underground and surface coal mining complexes across Northern and Central Appalachia. Contura owns large coal basins in Pennsylvania, Virginia and West Virginia which supply both metallurgical coal to produce steel and thermal coal to generate power.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

AMR vs INSM — Head-to-Head

Bigger by revenue
AMR
AMR
2.0× larger
AMR
$519.1M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+168.3% gap
INSM
152.6%
-15.7%
AMR
Higher net margin
AMR
AMR
121.2% more per $
AMR
-3.3%
-124.5%
INSM
More free cash flow
AMR
AMR
$254.2M more FCF
AMR
$-10.0M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
-22.4%
AMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMR
AMR
INSM
INSM
Revenue
$519.1M
$263.8M
Net Profit
$-17.3M
$-328.5M
Gross Margin
83.2%
Operating Margin
-4.1%
-121.2%
Net Margin
-3.3%
-124.5%
Revenue YoY
-15.7%
152.6%
Net Profit YoY
-711.2%
-39.5%
EPS (diluted)
$-1.35
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMR
AMR
INSM
INSM
Q4 25
$519.1M
$263.8M
Q3 25
$525.2M
$142.3M
Q2 25
$548.7M
$107.4M
Q1 25
$529.7M
$92.8M
Q4 24
$615.4M
$104.4M
Q3 24
$669.8M
$93.4M
Q2 24
$800.1M
$90.3M
Q1 24
$861.3M
$75.5M
Net Profit
AMR
AMR
INSM
INSM
Q4 25
$-17.3M
$-328.5M
Q3 25
$-5.5M
$-370.0M
Q2 25
$-5.0M
$-321.7M
Q1 25
$-33.9M
$-256.6M
Q4 24
$-2.1M
$-235.5M
Q3 24
$3.8M
$-220.5M
Q2 24
$58.9M
$-300.6M
Q1 24
$127.0M
$-157.1M
Gross Margin
AMR
AMR
INSM
INSM
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Q1 24
76.9%
Operating Margin
AMR
AMR
INSM
INSM
Q4 25
-4.1%
-121.2%
Q3 25
-0.5%
-257.1%
Q2 25
0.5%
-291.3%
Q1 25
-7.6%
-267.3%
Q4 24
1.6%
-220.6%
Q3 24
0.8%
-228.4%
Q2 24
8.8%
-319.8%
Q1 24
16.5%
-192.7%
Net Margin
AMR
AMR
INSM
INSM
Q4 25
-3.3%
-124.5%
Q3 25
-1.1%
-260.0%
Q2 25
-0.9%
-299.5%
Q1 25
-6.4%
-276.4%
Q4 24
-0.3%
-225.5%
Q3 24
0.6%
-236.0%
Q2 24
7.4%
-332.8%
Q1 24
14.7%
-208.1%
EPS (diluted)
AMR
AMR
INSM
INSM
Q4 25
$-1.35
$-1.55
Q3 25
$-0.42
$-1.75
Q2 25
$-0.38
$-1.70
Q1 25
$-2.60
$-1.42
Q4 24
$-0.09
$-1.30
Q3 24
$0.29
$-1.27
Q2 24
$4.49
$-1.94
Q1 24
$9.59
$-1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMR
AMR
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$415.6M
$1.4B
Total DebtLower is stronger
$9.8M
$546.8M
Stockholders' EquityBook value
$1.5B
$739.0M
Total Assets
$2.3B
$2.3B
Debt / EquityLower = less leverage
0.01×
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMR
AMR
INSM
INSM
Q4 25
$415.6M
$1.4B
Q3 25
$457.9M
$1.7B
Q2 25
$449.0M
$1.9B
Q1 25
$448.0M
$1.2B
Q4 24
$481.6M
$1.4B
Q3 24
$484.6M
$1.5B
Q2 24
$336.1M
$1.2B
Q1 24
$269.4M
$595.7M
Total Debt
AMR
AMR
INSM
INSM
Q4 25
$9.8M
$546.8M
Q3 25
$2.9M
$546.8M
Q2 25
$3.1M
$546.8M
Q1 25
$2.4M
$1.1B
Q4 24
$2.9M
$1.1B
Q3 24
$3.6M
$971.8M
Q2 24
$5.3M
$1.2B
Q1 24
$6.0M
$1.2B
Stockholders' Equity
AMR
AMR
INSM
INSM
Q4 25
$1.5B
$739.0M
Q3 25
$1.6B
$945.6M
Q2 25
$1.6B
$1.2B
Q1 25
$1.6B
$99.2M
Q4 24
$1.6B
$285.4M
Q3 24
$1.7B
$483.4M
Q2 24
$1.6B
$38.8M
Q1 24
$1.6B
$-464.8M
Total Assets
AMR
AMR
INSM
INSM
Q4 25
$2.3B
$2.3B
Q3 25
$2.3B
$2.4B
Q2 25
$2.4B
$2.5B
Q1 25
$2.4B
$1.8B
Q4 24
$2.4B
$2.0B
Q3 24
$2.5B
$2.1B
Q2 24
$2.5B
$1.8B
Q1 24
$2.5B
$1.2B
Debt / Equity
AMR
AMR
INSM
INSM
Q4 25
0.01×
0.74×
Q3 25
0.00×
0.58×
Q2 25
0.00×
0.44×
Q1 25
0.00×
11.31×
Q4 24
0.00×
3.93×
Q3 24
0.00×
2.01×
Q2 24
0.00×
30.66×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMR
AMR
INSM
INSM
Operating Cash FlowLast quarter
$19.0M
$-247.6M
Free Cash FlowOCF − Capex
$-10.0M
$-264.2M
FCF MarginFCF / Revenue
-1.9%
-100.1%
Capex IntensityCapex / Revenue
5.6%
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.8M
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMR
AMR
INSM
INSM
Q4 25
$19.0M
$-247.6M
Q3 25
$50.5M
$-219.8M
Q2 25
$53.2M
$-205.6M
Q1 25
$22.2M
$-262.1M
Q4 24
$56.3M
$-196.0M
Q3 24
$189.5M
$-180.9M
Q2 24
$138.1M
$-123.0M
Q1 24
$196.1M
$-184.0M
Free Cash Flow
AMR
AMR
INSM
INSM
Q4 25
$-10.0M
$-264.2M
Q3 25
$25.4M
$-222.2M
Q2 25
$18.6M
$-209.1M
Q1 25
$-16.3M
$-272.2M
Q4 24
$13.6M
$-202.8M
Q3 24
$158.0M
$-184.6M
Q2 24
$77.0M
$-129.7M
Q1 24
$132.5M
$-188.7M
FCF Margin
AMR
AMR
INSM
INSM
Q4 25
-1.9%
-100.1%
Q3 25
4.8%
-156.1%
Q2 25
3.4%
-194.6%
Q1 25
-3.1%
-293.2%
Q4 24
2.2%
-194.1%
Q3 24
23.6%
-197.6%
Q2 24
9.6%
-143.6%
Q1 24
15.4%
-250.0%
Capex Intensity
AMR
AMR
INSM
INSM
Q4 25
5.6%
6.3%
Q3 25
4.8%
1.7%
Q2 25
6.3%
3.2%
Q1 25
7.3%
10.8%
Q4 24
6.9%
6.5%
Q3 24
4.7%
3.9%
Q2 24
7.6%
7.5%
Q1 24
7.4%
6.2%
Cash Conversion
AMR
AMR
INSM
INSM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
49.81×
Q2 24
2.34×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons